Objective To summarize the roles of tumor initiating cells (TICs) and epithelial-mesenchymal transition (EMT) in tumor metastasis and drug resistance. Methods Domestic and international publications online which involving TICs,EMT,and its roles in tumor metastasis and drug resistance in recent years were reviewed. Results TICs were self-renewal cells and had the ability to give rise to more differentiated cell types,and played an important role in tumor metastasis and drug resistance. Various markers had been used to identify TICs,such as CD133,CD44,and so on. EMT was the process by which epithelial cells losed polarity and detach from the epithelial sheet, and acquired a motile mesenchymal phenotype,usually observed in embryo development and wound healing. It also could promote tumor progression and metastasis,and may also be responsible for the ability of tumors to evade the body’s immune response. EMT may be the reasons of TICs that drived tumor metastasis and recurrence. TICs or EMT as a target for treatments may effectively prevent tumor recurrence and improve patient’s survival. Conclusions EMT is probably the mechanism that TICs promote tumor metastasis and drug resistance. More effective target therapies for cancer may be found if we know more about TICs and EMT.